Skip to main content
PHARMARESEARCH BIO Co., Ltd. logo

PHARMARESEARCH BIO Co., Ltd. — Investor Relations & Filings

Ticker · 217950 ISIN · KR7217950005 KO Manufacturing
Open in API
Filings indexed 162 across all filing types
Latest filing 2021-11-10 Delisting Announcement
Country KR South Korea
Listing KO 217950

About PHARMARESEARCH BIO Co., Ltd.

http://www.pr-bio.co.kr/eng/

PHARMARESEARCH BIO Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. The company leverages marine biotechnology to research, develop, and produce innovative biological products aimed at enhancing human health. Its core activities center on the development of raw materials for cell and tissue regeneration, such as Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) derived from salmon DNA. The company's research and development pipeline also includes other biological products, such as toxin-based therapeutics, to address various medical and aesthetic needs.

Recent filings

Filing Released Lang Actions
주권매매거래정지기간변경(풍문사유(식약처의 보톡스 허가취소 착수설) 미해소)
Delisting Announcement Classification · 100% confidence The document is a formal notice regarding the suspension of stock trading for PharmaResearch Bio due to unresolved rumors regarding regulatory actions (KFDA license cancellation). It cites specific exchange regulations (KONEX market disclosure rules) and provides details on the duration of the trading halt. As this is a regulatory announcement regarding market operations and trading status that does not fit into specific categories like M&A or dividend announcements, it falls under the general regulatory filing category.
2021-11-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status and changes in ownership for (주)파마리서치바이오. This type of filing is specifically used to notify the market of significant changes in share ownership (crossing thresholds) by major shareholders and their special relations. Therefore, it falls under the 'Major Shareholding Notification' category.
2021-06-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and the relationship between the reporter (Min Hong-ki) and the issuer (PharmaResearchBio). This falls under the category of Major Shareholding Notification.
2021-06-08 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically the dissolution of special relationships due to the resignation of directors and changes in the representative reporter. This falls under the category of Major Shareholding Notification (MRQ), as it tracks significant changes in ownership levels and relationships.
2021-06-03 Korean
기업설명회(IR)개최결과
Report Publication Announcement Classification · 100% confidence The document is a short, structured announcement confirming that an Investor Relations (IR) meeting was held on May 21, 2021. It provides details about the event, such as the time, location, attendees, and where the presentation materials can be found. Since it is a brief notification regarding the occurrence of an event and the availability of materials rather than the presentation itself, it falls under the category of a Report Publication Announcement or general regulatory filing notification.
2021-05-21 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) meeting. It provides details such as the date, time, location (online), target audience, and purpose of the meeting. Since it is an announcement of an upcoming event rather than the presentation materials themselves or a transcript, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2021-05-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.